États-Unis · Plateformes & données · MarketBeat

Zymeworks (NASDAQ:ZYME) Price Target Raised to $39.00

Publié par MarketBeat · États-Unis il y a 26 min

Image from MarketBeat Media, LLC. · MarketBeat

Résumé détaillé

Citizens Jmp raised their price objective on Zymeworks from $32.00 to $39.00 and gave the stock a "market outperform" rating in a research note on Friday.

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

Zymeworks (NASDAQ:ZYME) Price Target Raised to $39.00

Résumé détaillé

À lire aussi

Moving iMage Technologies GAAP EPS of $0.02, revenue of $6.1M

ADI Global Distribution: 3 Key Takeaways for Long-Term Investors

Midterm elections provided the hyperscalers with the excuse they needed to cut back on spending, says Jefferies strategist

Thursday’s insider activity: Major buys and sells disclosed

U-wifi Names Charlie Vogt to its Board of Directors

Soon We’ll Need an Advanced AI Chip … Just to Understand the Nvidia Drama

Zymeworks (NASDAQ:ZYME) Price Target Raised to $39.00

Résumé détaillé

Partager

À lire aussi

Moving iMage Technologies GAAP EPS of $0.02, revenue of $6.1M

ADI Global Distribution: 3 Key Takeaways for Long-Term Investors

Midterm elections provided the hyperscalers with the excuse they needed to cut back on spending, says Jefferies strategist

Thursday’s insider activity: Major buys and sells disclosed

U-wifi Names Charlie Vogt to its Board of Directors

Soon We’ll Need an Advanced AI Chip … Just to Understand the Nvidia Drama